Abstract
Prevalence and predictors of transmitted drug resistance (TDR),
defined as the presence of at least one WHO surveillance drug
resistance mutation (SDRM), were investigated in antiretroviral naı
¨ve HIV-1-infected patients, with a genotypic resistance test
(GRT) performed £6 months before starting cART between
2000 and 2010. 3163 HIV-1 sequences were selected (69% subtype
B). Overall, the prevalence of TDR was 12% (13.2% subtype
B, 9% non-B). TDR significantly declined overall and for the
single drug classes. Older age independently predicted increased
odds of TDR, whereas a more recent GRT, a higher HIV-RNA
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 299-304 |
| Numero di pagine | 6 |
| Rivista | Clinical Microbiology and Infection |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2012 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- HAART
- HIV
Fingerprint
Entra nei temi di ricerca di 'Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver